Updated Vaccine Dosage Recommendations
The recombinant zoster vaccine (Shingrix) is recommended for patients starting at age 50. After the first dose, a second dose is recommended based on the patient's dosage schedule, which then completes the Zoster Immunization series. The two-dose Shingrix vaccine is also recommended for adults who had previously received the Zoster live vaccine (Zostavax).